These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20609614)

  • 1. Functional pathway pharmacology: chemical tools, pathway knowledge and mechanistic model-based interpretation of experimental data.
    Hendriks BS
    Curr Opin Chem Biol; 2010 Aug; 14(4):489-97. PubMed ID: 20609614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug target identification in sphingolipid metabolism by computational systems biology tools: metabolic control analysis and metabolic pathway analysis.
    Ozbayraktar FB; Ulgen KO
    J Biomed Inform; 2010 Aug; 43(4):537-49. PubMed ID: 20348024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of cell signaling and drug action via mass spectrometry-based systems level phosphoproteomics.
    Tedford NC; Hall AB; Graham JR; Murphy CE; Gordon NF; Radding JA
    Proteomics; 2009 Mar; 9(6):1469-87. PubMed ID: 19294625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting ADME properties and side effects: the BioPrint approach.
    Krejsa CM; Horvath D; Rogalski SL; Penzotti JE; Mao B; Barbosa F; Migeon JC
    Curr Opin Drug Discov Devel; 2003 Jul; 6(4):470-80. PubMed ID: 12951810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-based assays in GPCR drug discovery.
    Siehler S
    Biotechnol J; 2008 Apr; 3(4):471-83. PubMed ID: 18383022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational chemistry approaches to drug discovery in signal transduction.
    Fischer PM
    Biotechnol J; 2008 Apr; 3(4):452-70. PubMed ID: 18412174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of mechanistic pathway models in drug discovery: p38 pathway.
    Hendriks BS; Hua F; Chabot JR
    Biotechnol Prog; 2008; 24(1):96-109. PubMed ID: 17918858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of natural product signal transduction agents.
    Koehn FE
    Curr Opin Biotechnol; 2006 Dec; 17(6):631-7. PubMed ID: 17049224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotography for multi-target SAR analysis in the context of biological pathways.
    Lounkine E; Kutchukian P; Petrone P; Davies JW; Glick M
    Bioorg Med Chem; 2012 Sep; 20(18):5416-27. PubMed ID: 22405595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The application of cell-based label-free technology in drug discovery.
    Xi B; Yu N; Wang X; Xu X; Abassi YA
    Biotechnol J; 2008 Apr; 3(4):484-95. PubMed ID: 18412175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploiting complexity and the robustness of network architecture for drug discovery.
    Hellerstein MK
    J Pharmacol Exp Ther; 2008 Apr; 325(1):1-9. PubMed ID: 18202293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.
    Bender A; Scheiber J; Glick M; Davies JW; Azzaoui K; Hamon J; Urban L; Whitebread S; Jenkins JL
    ChemMedChem; 2007 Jun; 2(6):861-73. PubMed ID: 17477341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging applications of network and pathway analysis in drug discovery and development.
    Ganter B; Giroux CN
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):86-94. PubMed ID: 18175271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical network-based drug-target prediction.
    Klipp E; Wade RC; Kummer U
    Curr Opin Biotechnol; 2010 Aug; 21(4):511-6. PubMed ID: 20554441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug targets discovery based on dynamic signal transduction networks].
    Wang J; Li XJ
    Yao Xue Xue Bao; 2010 Jan; 45(1):1-8. PubMed ID: 21351442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DrugBank: a comprehensive resource for in silico drug discovery and exploration.
    Wishart DS; Knox C; Guo AC; Shrivastava S; Hassanali M; Stothard P; Chang Z; Woolsey J
    Nucleic Acids Res; 2006 Jan; 34(Database issue):D668-72. PubMed ID: 16381955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and application of physiologically based pharmacokinetic-modeling tools to support drug discovery.
    Lüpfert C; Reichel A
    Chem Biodivers; 2005 Nov; 2(11):1462-86. PubMed ID: 17191947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational analysis of mTOR signaling pathway: bifurcation, carcinogenesis, and drug discovery.
    Wang G; Krueger GR
    Anticancer Res; 2010 Jul; 30(7):2683-8. PubMed ID: 20682998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling promiscuity based on in vitro safety pharmacology profiling data.
    Azzaoui K; Hamon J; Faller B; Whitebread S; Jacoby E; Bender A; Jenkins JL; Urban L
    ChemMedChem; 2007 Jun; 2(6):874-80. PubMed ID: 17492703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.